Charles Schwab’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$140M Buy
666,633
+10,205
+2% +$2.19M 0.02% 610
2026
Q1
$145M Buy
656,428
+22,056
+3% +$5.4M 0.02% 550
2025
Q4
$161M Buy
634,372
+7,403
+1% +$1.86M 0.03% 495
2025
Q3
$155M Buy
626,969
+5,615
+0.9% +$1.34M 0.02% 498
2025
Q2
$149M Buy
621,354
+40,572
+7% +$9.45M 0.03% 499
2025
Q1
$132M Buy
580,782
+10,945
+2% +$2.41M 0.02% 524
2024
Q4
$117M Buy
569,837
+18,384
+3% +$4.03M 0.02% 578
2024
Q3
$134M Buy
551,453
+6,334
+1% +$1.48M 0.03% 520
2024
Q2
$120M Buy
545,119
+5,433
+1% +$1.18M 0.02% 554
2024
Q1
$121M Buy
539,686
+16,169
+3% +$3.65M 0.03% 524
2023
Q4
$115M Buy
523,517
+10,404
+2% +$2.2M 0.03% 503
2023
Q3
$113M Buy
513,113
+5,167
+1% +$1.17M 0.03% 456
2023
Q2
$114M Buy
507,946
+2,304
+0.5% +$461K 0.03% 462
2023
Q1
$96.7M Sell
505,642
-15,285
-3% -$2.95M 0.03% 512
2022
Q4
$96.2M Buy
520,927
+18,054
+4% +$3.17M 0.03% 492
2022
Q3
$83.6M Buy
502,873
+24,455
+5% +$4.98M 0.03% 504
2022
Q2
$98.6M Buy
478,418
+489
+0.1% +$110K 0.03% 461
2022
Q1
$116M Buy
477,929
+11,738
+3% +$2.72M 0.03% 459
2021
Q4
$113M Buy
466,191
+15,595
+3% +$3.56M 0.03% 480
2021
Q3
$92M Sell
450,596
-220,075
-33% -$47.1M 0.03% 531
2021
Q2
$138M Buy
670,671
+66,188
+11% +$13.3M 0.05% 372
2021
Q1
$115M Buy
604,483
+8,122
+1% +$1.51M 0.04% 396
2020
Q4
$113M Buy
596,361
+19,448
+3% +$3.63M 0.04% 366
2020
Q3
$102M Sell
576,913
-28,415
-5% -$4.54M 0.05% 353
2020
Q2
$92.9M Buy
605,328
+1,265
+0.2% +$193K 0.05% 375
2020
Q1
$84.6M Sell
604,063
-5,040
-0.8% -$754K 0.05% 332
2019
Q4
$92.8M Buy
609,103
+147,284
+32% +$21.6M 0.05% 351
2019
Q3
$66.7M Buy
461,819
+25,732
+6% +$3.84M 0.04% 441
2019
Q2
$64.9M Buy
436,087
+42,658
+11% +$5.7M 0.04% 448
2019
Q1
$50.4M Sell
393,429
-42,427
-10% -$4.99M 0.03% 541
2018
Q4
$46.6M Buy
435,856
+3,686
+0.9% +$412K 0.04% 483
2018
Q3
$49.4M Buy
432,170
+20,660
+5% +$2.34M 0.03% 540
2018
Q2
$43.2M Buy
411,510
+29,937
+8% +$3.01M 0.03% 563
2018
Q1
$35.6M Buy
381,573
+21,834
+6% +$1.99M 0.03% 644
2017
Q4
$31.5M Buy
359,739
+13,122
+4% +$1.17M 0.03% 671
2017
Q3
$30.6M Buy
346,617
+20,932
+6% +$1.77M 0.03% 630
2017
Q2
$26.5M Buy
325,685
+77,516
+31% +$5.89M 0.02% 660
2017
Q1
$17.2M Buy
248,169
+39,153
+19% +$2.71M 0.02% 918
2016
Q4
$14.1M Sell
209,016
-21,376
-9% -$1.45M 0.02% 1004
2016
Q3
$16.8M Buy
230,392
+19,144
+9% +$1.35M 0.02% 797
2016
Q2
$14.5M Sell
211,248
-166,452
-44% -$11.7M 0.02% 832
2016
Q1
$26.8M Buy
377,700
+6,030
+2% +$408K 0.04% 500
2015
Q4
$28M Buy
371,670
+112,317
+43% +$8.11M 0.04% 465
2015
Q3
$16.9M Buy
259,353
+11,310
+5% +$747K 0.02% 637
2015
Q2
$16M Buy
248,043
+10,682
+5% +$720K 0.02% 688
2015
Q1
$16.7M Buy
237,361
+33,943
+17% +$2.24M 0.02% 652
2014
Q4
$13.2M Buy
203,418
+1,816
+0.9% +$112K 0.02% 718
2014
Q3
$10.9M Buy
201,602
+1,913
+1% +$104K 0.02% 757
2014
Q2
$10.7M Buy
199,689
+775
+0.4% +$39.9K 0.02% 777
2014
Q1
$9.5M Sell
198,914
-204,833
-51% -$9.59M 0.02% 841
2013
Q4
$19.4M Buy
403,747
+9,950
+3% +$455K 0.04% 438
2013
Q3
$17.2M Sell
393,797
-697
-0.2% -$30.3K 0.04% 446
2013
Q2
$17.3M Buy
+394,494
New +$17M 0.04% 416

Other funds holding STE

Charles Schwab's STE Position: Q2 2026 in Review

Charles Schwab increased its Steris (STE) stake by 1.6% in Q2 2026, buying an estimated $2.19M and bringing the position to 666,633 shares worth $140M. The position accounts for 0.02% of the portfolio, ranked #610.

Charles Schwab first reported a position in STE in Q2 2013 and has held it in 53 quarters since. The position peaked at $161M in Q4 2025. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Charles Schwab held 666,633 shares of Steris worth $140M as of Q2 2026.
  • Charles Schwab bought 10,205 Steris shares in Q2 2026, an estimated $2.19M.
  • Steris made up 0.02% of Charles Schwab's portfolio in Q2 2026, its #610 holding.
  • Charles Schwab first reported a position in Steris in Q2 2013 and has held it in 53 quarters since.
  • Charles Schwab's Steris position peaked at $161M in Q4 2025.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.